7/31/24 16:19 | 7/30/24 | ADVM | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T | | P | 613 | 7.15 | 0 | 86 | 4 | 2,373 | I | | | | | | | | | | | | | | |
7/18/24 21:16 | 7/17/24 | ADVM | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T | | P.m | 1,786 | 8.26 | 0 | 216 | 10 | 2,287 | I | | | | | | | | | | | | | | |
2/9/24 17:51 | 2/7/24 | ADVM | Health | BioPrd | Biological Products, (No Diag | Scopa James Paul | CA | D | | P | 135 | 1.35 | 0 | 100 | 999% | 103 | D | | | | | | | | | | | | | | |
2/9/24 17:50 | 2/7/24 | ADVM | Health | BioPrd | Biological Products, (No Diag | Lupher, Jr. Mark L. | CA | D | | P | 176 | 1.35 | 0 | 130 | New | 130 | D | | | | | | | | | | | | | | |
6/9/23 16:26 | 6/7/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Rubinstein Linda M | CA | O | CFO | P | 145 | 1.45 | 0 | 100 | New | 100 | D | | | | | | | | | | | | | | |
5/24/22 16:47 | 5/23/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | P | 17 | 0.8400 | 0 | 20 | 999% | 21 | D | | | | | | | | | | | | | | |
5/19/22 19:43 | 5/17/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Beckman Richard | CA | O | Chief Me | P | 8 | 0.8228 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
5/18/22 16:43 | 5/16/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Svoronos Dawn | CA | D | | P | 26 | 0.8526 | 0 | 30 | 150 | 50 | D | | | | | | | | | | | | | | |
5/17/22 18:28 | 5/13/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | D'Souza Rupert | CA | O | CFO | P.m | 17 | 0.8429 | 0 | 20 | 999% | 21 | D | | | | | | | | | | | | | | |
4/22/22 17:00 | 4/20/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Fischer Laurent | CA | DO | CEO,P,Di | P | 28 | 1.11 | 0 | 25 | 3 | 762 | D | | | | | | | | | | | | | | |
4/20/22 16:35 | 4/19/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Soparkar Peter | CA | O | See Rema | P | 25 | 1.14 | 0 | 22 | 8 | 281 | D | | | | | | | | | | | | | | |